Pharmacodynamic and kinetic effect of rabeprazole on serum gastrin level in relation to CYP2C19 polymorphism in Chinese Hans

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 29

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

379

HTML

2329

Figures (1-1)

205

Tables (1-3)

194

Sum=3107

Aug 7, 2006 (publication date) through Nov 27, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Aug 7, 2006; 12(29): 4750-4753
Published online Aug 7, 2006. doi: 10.3748/wjg.v12.i29.4750

Table 3 Serum gastrin level with reference to CYP2C19 polymorphism

^aP < 0.05, AUC on d 1 vs AUC on d 8.

Citation: Hu YM, Mei Q, Xu XH, Hu XP, Hu NZ, Xu JM. Pharmacodynamic and kinetic effect of rabeprazole on serum gastrin level in relation to CYP2C19 polymorphism in Chinese Hans. World J Gastroenterol 2006; 12(29): 4750-4753
URL: https://www.wjgnet.com/1007-9327/full/v12/i29/4750.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i29.4750